VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.
Process & Project Management
Last Updated: 2026-06-03 00:14:39
Abstract
The course provides an overview of Project Management and its relevance in the pharmaceutical industry including strategic planning, risk mitigation, and continuous improvement through methodologies like Lean and Six Sigma. A strong focus is on quality control, innovation, and understanding business processes, including mergers and partnerships, as essential to ensure successful outcomes
Objective
Students 1. can describe the phases of the project life cycle: initiation, planning, execution, monitoring, and closure and can name the most important functions in a drug development project. 2. understand how strategic planning, resource management, and risk mitigation lead to effective project management in pharmaceutical projects, with specific example of QC Labs. 3. know techniques for process mapping, such as SIPOC and Swim lanes and understand the importance of process efficiency in the pharmaceutical industry. 4. apply their knowledge of project management and of Lean Six Sigma methodologies, particularly the DMAIC (Define, Measure, Analyze, Improve, Control) to improve processes. 5. know the differences between managing a project and driving large-scale transformation, including the role of change management and governance. 6. can explain how to make a site divestment from a Quality standpoint 7. can describe various types of strategic transactions in the pharmaceutical industry, including mergers and acquisitions, strategic partnerships, licensing agreements, and their relevance 8. can explain why business processes, particularly deal types like mergers and partnerships, are crucial and how they shape company strategies, influencing research priorities and market positioning.
Content
In the pharmaceutical industry, effective project management is essential for navigating the complexities of drug development. This involves strategic planning, resource management, and risk mitigation to ensure successful project outcomes. A key component is the development of a new Quality Control (QC) lab business case, which requires a thorough analysis of costs, compliance, and technological advancements to enhance testing capabilities. Continuous improvement is vital for maintaining competitiveness. By adopting methodologies such as Lean and Six Sigma, companies can streamline operations, reduce waste, and enhance value delivery. Embracing a mindset of perpetual enhancement allows pharmaceutical companies to adapt to market demands and sustain innovation. A strong quality culture is central to pharmaceutical success, fostering an environment where continuous improvement and regulatory adherence are priorities. This culture empowers teams to identify inefficiencies and implement innovative solutions, thereby improving product quality and patient safety. Finally understanding business processes, particularly deal types like mergers and partnerships, is crucial. These deals shape company strategies, influencing research priorities and market positioning. A comprehensive grasp of these processes aids in informed decision-making aligned with organizational goals.
General Information
- Language
- English
- Levels
- MSC
- Frequency
- Yearly recurring
Examination
- Type
- ungraded semester performance
Registration & Places
Course Components
| Type | Title | Time & Place | Hours |
|---|---|---|---|
| lecture with exercise |
Process & Project Management
Block course (see special program)
Room HCP E47.2
|
No time listed | 16 h semesterly |